《LANCET,4月6日,School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-04-07
  • School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review

    Prof Russell M Viner, PhD

    Simon J Russell, PhD

    Helen Croker, PhD

    Jessica Packer, MEpi

    Joseph Ward, MBBS

    Claire Stansfield, PhD

    Published:April 06, 2020DOI:https://doi.org/10.1016/S2352-4642(20)30095-X

    In response to the coronavirus disease 2019 (COVID-19) pandemic, 107 countries had implemented national school closures by March 18, 2020. It is unknown whether school measures are effective in coronavirus outbreaks (eg, due to severe acute respiratory syndrome [SARS], Middle East respiratory syndrome, or COVID-19). We undertook a systematic review by searching three electronic databases to identify what is known about the effectiveness of school closures and other school social distancing practices during coronavirus outbreaks. We included 16 of 616 identified articles. School closures were deployed rapidly across mainland China and Hong Kong for COVID-19. However, there are no data on the relative contribution of school closures to transmission control. Data from the SARS outbreak in mainland China, Hong Kong, and Singapore suggest that school closures did not contribute to the control of the epidemic. Modelling studies of SARS produced conflicting results. Recent modelling studies of COVID-19 predict that school closures alone would prevent only 2–4% of deaths, much less than other social distancing interventions. Policy makers need to be aware of the equivocal evidence when considering school closures for COVID-19, and that combinations of social distancing measures should be considered. Other less disruptive social distancing interventions in schools require further consideration if restrictive social distancing policies are implemented for long periods.

  • 原文来源:https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30095-X/fulltext
相关报告
  • 《LANCET,4月6日,Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-04-07
    • Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Jason Phua, MRCP,Li Weng, MD,Lowell Ling, MRCP,Moritoki Egi, MD,Prof Chae-Man Lim, MD,Prof Jigeeshu Vasishtha Divatia, MD Published:April 06, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30161-2 As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Streamlining of workflows for rapid diagnosis and isolation, clinical management, and infection prevention will matter not only to patients with COVID-19, but also to health-care workers and other patients who are at risk from nosocomial transmission. Management of acute respiratory failure and haemodynamics is key. ICU practitioners, hospital administrators, governments, and policy makers must prepare for a substantial increase in critical care bed capacity, with a focus not just on infrastructure and supplies, but also on staff management. Critical care triage to allow the rationing of scarce ICU resources might be needed. Researchers must address unanswered questions, including the role of repurposed and experimental therapies. Collaboration at the local, regional, national, and international level offers the best chance of survival for the critically ill.
  • 《Lancet,6月26日,COVID-19 in 7780 pediatric patients: A systematic review》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-27
    • COVID-19 in 7780 pediatric patients: A systematic review Ansel Hoang Kevin Chorath † Axel Moreira Mary Evans Finn Burmeister-Morton Fiona Burmeister et al. Open AccessPublished:June 26, 2020DOI:https://doi.org/10.1016/j.eclinm.2020.100433 Abstract Background Studies summarizing the clinical picture of COVID-19 in children are lacking. This review characterizes clinical symptoms, laboratory, and imaging findings, as well as therapies provided to confirmed pediatric cases of COVID-19. Methods Adhering to PRISMA guidelines, we searched four medical databases (PubMed, LitCovid, Scopus, WHO COVID-19 database) between December 1, 2019 to May 14, 2020 using the keywords “novel coronavirus”, “COVID-19” or “SARS-CoV-2”. We included published or in press peer-reviewed cross-sectional, case series, and case reports providing clinical signs, imaging findings, and/or laboratory results of pediatric patients who were positive for COVID-19. Risk of bias was appraised through the quality assessment tool published by the National Institutes of Health. PROSPERO registration # CRD42020182261.